Cardio-renal Correlations and Epicardial Adipose Tissue in Patients with Type 2 Diabetes

1. Cernea S. Heart failure and chronic kidney disease in type 2 diabetes. Journal of Interdisciplinary Medicine. 2016;1:252-258.10.1515/jim-2016-0066Search in Google Scholar

2. Battiprolu PK, Gillette TG, Wang ZV, et al. Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets. Drug Discov Today Dis Mech. 2010;7:e135-e143.10.1016/j.ddmec.2010.08.001Open DOISearch in Google Scholar

3. McMurray JJ, Gerstein HC, Holman RR, et al. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored. Lancet Diabetes Endocrinol. 2014;2:843-851.10.1016/S2213-8587(14)70031-2Open DOISearch in Google Scholar

4. Matloch Z, Kotulák T, Haluzík M. The role of epicardial adipose tissue in heart disease. Physiol Res. 2016;65:23-32.10.33549/physiolres.93303626596323Search in Google Scholar

5. Wang CP, Hsu HL, Hung WC, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf). 2009;70:876-882.10.1111/j.1365-2265.2008.03411.x18778397Open DOISearch in Google Scholar

6. Iacobellis G, Barbaro G, Gerstein HC. Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol. 2008;128:424-426.10.1016/j.ijcard.2007.12.07218375002Search in Google Scholar

7. Nakanishi K, Fukuda S, Tanaka A, et al. Epicardial Adipose Tissue Accumulation Is Associated With Renal Dysfunction and Coronary Plaque Morphology on Multidetector Computed Tomography. Circ J. 2016;80:196-201.10.1253/circj.CJ-15-047726497330Open DOISearch in Google Scholar

8. Doesch C, Haghi D, Flüchter S, et al. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson. 2010;12:40.10.1186/1532-429X-12-40291477220624277Search in Google Scholar

9. American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care. 2017;40(Suppl 1):S1-S135.10.2337/dci17-000728637893Search in Google Scholar

10. Laborator Synevo. Referintele specifice tehnologiei de lucru utilizate. Available at: https://www.synevo.ro/hemoglobina-glicata-hb-a1c/Search in Google Scholar

11. Laborator Synevo. Referintele specifice tehnologiei de lucru utilizate. Available at: https://www.synevo.ro/colesterol-ldl/Search in Google Scholar

12. Laborator Synevo. Referintele specifice tehnologiei de lucru utilizate. Available at: https://www.synevo.ro/creatinina-serica/Search in Google Scholar

13. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150:604-612.10.7326/0003-4819-150-9-200905050-00006276356419414839Search in Google Scholar

14. Durnin J, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32:77–97.10.1079/BJN197400604843734Search in Google Scholar

15. Nagueh SF, Smiseth OA, Appleton CP, et al. ASE/EACVI GUIDELINES AND STANDARDS. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:1321-1360.10.1093/ehjci/jew08227422899Search in Google Scholar

16. Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging. 2015;16:577-605.10.1016/j.echo.2015.05.00226140936Search in Google Scholar

17. Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012;55:2154-2162.10.1007/s00125-012-2579-0339070822618812Open DOISearch in Google Scholar

18. Henry RM, Paulus WJ, Kamp O, et al. Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study. Neth J Med. 2008;66:110-117.Search in Google Scholar

19. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115:3213–3223.10.1161/CIRCULATIONAHA.106.67959717592090Search in Google Scholar

20. Ojji DB, Adebiyi AA, Oladapo OO, et al. Left ventricular geometric patterns in normotensive type 2 diabetic patients in Nigeria: an echocardiographic study. Prev Cardiol. 2009;12:184-188.10.1111/j.1751-7141.2009.00033.x19751482Search in Google Scholar

21. De Jong KA, Czeczor JK, Sithara S, et al. Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study. Cardiovasc Diabetol. 2017;16:21.10.1186/s12933-017-0504-z529977628178970Search in Google Scholar

22. Masugata H, Senda S, Goda F, et al. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors? Clin Exp Hypertens. 2010;32:113-120.10.3109/1064196090299314520374184Open DOISearch in Google Scholar

23. Salazar J, Luzardo E, Mejías JC, et al. Epicardial Fat: Physiological, Pathological, and Therapeutic Implications. Cardiol Res Pract. 2016;2016:1291537.10.1155/2016/1291537486177527213076Search in Google Scholar

24. Parisi V, Rengo G, Pagano G, et al. Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis. Int J Cardiol. 2015;186:167-169.10.1016/j.ijcard.2015.03.20125819894Search in Google Scholar

25. Noyes AM, Dua K, Devadoss R, et al. Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J Diabetes. 2014;5:868-876.10.4239/wjd.v5.i6.868426587325512789Open DOISearch in Google Scholar

26. Nasrallah MP, Ziyadeh FN. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin Nephrol. 2013;33:54-65.10.1016/j.semnephrol.2012.12.00523374894Search in Google Scholar

27. Ortega Moreno L, Lamacchia O, Copetti M, et al. Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes. PLoS One. 2015;10:e0140631.10.1371/journal.pone.0140631460570026465607Search in Google Scholar

28. Puurunen VP, Lepojärvi ES, Piira OP, et al. High plasma leptin levels are associated with impaired diastolic function in patients with coronary artery disease. Peptides. 2016;84:17-21.10.1016/j.peptides.2016.08.00227524739Open DOISearch in Google Scholar

29. Dey D, Nakazato R, Li D, et al. Epicardial and thoracic fat - Noninvasive measurement and clinical implications. Cardiovasc Diagn Ther. 2012;2:85-93.Search in Google Scholar

30. Rabkin SW, Campbell H. Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis. Obes Rev. 2015;16:406-415.10.1111/obr.1227025753297Search in Google Scholar

31. Benedek T, Oprincariu D, Rat N, et al. The Assessment of Epicardial Adipose Tissue in Acute Coronary Syndrome Patients. A Systematic Review. Journal of Cardiovascular Emergencies. 2017;3:18-29.10.1515/jce-2017-0003Search in Google Scholar

32. Cardoso AF, Furtado MS, Grindler J, et al. Epicardial Fat Thickness Correlates with P-wave Duration, Left Atrial Size and Decreased Left Ventricular Systolic Function in Morbid Obesity. Nutr Metab Cardiovasc Dis. 2017;27:473-582.Search in Google Scholar